OLIG3 Antikörper (Middle Region)
Kurzübersicht für OLIG3 Antikörper (Middle Region) (ABIN453775)
Target
Alle OLIG3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody reacts to OLIG3.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human OLIG3
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- OLIG3 (Oligodendrocyte Transcription Factor 3 (OLIG3))
-
Andere Bezeichnung
- OLIG3
-
Hintergrund
- OLIG3 may determine the distinct specification program of class A neurons in the dorsal part of the spinal cord and suppress specification of class B neurons.Synonyms: BHLHB7, Class B basic helix-loop-helix protein 7, OLIG-3, Oligo3, Oligodendrocyte transcription factor 3, bHLHB7
-
Gen-ID
- 167826
-
NCBI Accession
- NP_786923
-
UniProt
- Q7RTU3
Target
-